Cogent Biosciences Inc (COGT)

SG&A Expense Growth

12.69%

Quarterly · Period ending:

COGT logo

COGT SG&A Expense Growth

Latest reported12.69%
COGT Quarterly SG&A Growth (QoQ) (0.00% → 12.69%)
High-resolution chart · PNG

COGT sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cogent Biosciences Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
12.6939%
17.9995%
66.6017%
7.3772%
12.3908%
1.8393%
-0.9407%
16.9127%
4.0623%
1.9981%
0.5924%
15.084%
14.0992%
2.7988%
1.7139%
7.9831%
7.1957%
16.0359%
2.0912%
2.3858%
6.9108%
-14.2296%
-4.4659%
99.7859%
-23.7343%
36.3771%
-0.9923%
-11.1365%
22.9225%
21.8689%
-13.646%
19.6059%
85.9962%
-26.1624%
8.8369%
36.3543%
2.8602%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.